English

    Overview

  • Dr. Rohit Tewari is a highly dedicated and academically driven Surgical Oncologist who specialises in managing complex oncologic, gastrointestinal (GI), hepato-pancreato-biliary (HPB), and minimally invasive surgeries. He holds a master's degree in General Surgery (MS) from R.G. Kar Medical College, Kolkata, and his super-speciality MCh in Surgical Oncology from the State Cancer Institute in Guwahati, a premier unit of Tata Trusts.

  • Throughout his career, he has built a massive cumulative experience, having performed and assisted in over 1,000 surgical oncology cases spanning various oncology disciplines. He regularly performs highly complex, major oncological resections independently, including VATS Esophagectomies, Whipple’s Pancreaticoduodenectomies, Radical Hysterectomies, Gastrostomies, and compartment resections for retroperitoneal tumours. He is heavily invested in minimally invasive treatment methods, possessing a Fellowship of Minimal Access Surgery (FMAS) and extensive hands-on training in advanced laparoscopy and robotic-assisted surgeries.

  • His surgical clinical expertise also covers specialised, regional treatments for advanced cancers, including Cytoreductive Surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). He has served across multiple renowned healthcare institutions, gaining valuable clinical perspective as a Consultant in Laparoscopic & General Surgery, a Senior Resident in Urology, and a Resident in Orthopaedics at Safdarjung Hospital, New Delhi. He is an active clinical researcher who has published in the prestigious Indian Journal of Surgical Oncology (2025) and is currently working on an active project studying emerging trends in early-onset rectal cancer. He is highly recognised within the national surgical community, having won the Best Video Presentation at IASO MIDCON 2025 alongside presenting his research at the Indian Cancer Congress and IASO NATCON. He holds active professional memberships in elite global and national oncology organisations, including the Society of Surgical Oncology (SSO), the Indian Association of Surgical Oncology (IASO), and the Association of Surgeons of India (ASI).

  • Field of Expertise

  • Gastrointestinal Oncology
  • Hepato-Pancreato-Biliary Surgery
  • Minimally Invasive & Robotic Surgery
  • Gynaecologic Oncology
  • Head and Neck Oncology
  • Peritoneal Surface Malignancy & HIPEC
  • Uro-Oncology
  • Languages Spoken

  • English
  • Nepali
  • Hindi
  • Bengali
  • Assamese
  • Awards & Achievements

  • Best Video Presentation- IASO MIDCON 2025 (Puri, Odisha)
  • Oral Paper Presentation- IASO NATCON 2024 (Bangalore, Karnataka)
  • Poster Presentation- Indian Cancer Congress 2023 (Mumbai, Maharashtra)
  • Poster & Video Presentation- ASI SASICON 2017 (Kolkata, West Bengal)
  • Talks & Publications

  • Dissertation: Evaluation of Metabolic Tumour Response to Neoadjuvant Therapy on 18F-FDG PET-CT Scan for Patients with Carcinoma of the Oesophagus as a Predictor of Pathological Response and Their Clinico-pathological Outcome.
  • Publication: Tewari R, et al. Suspicious Gallbladder Wall Thickening: A Tertiary Cancer Institute Observation on Malignant Potential. Indian Journal of Surgical Oncology, 2025.
  • Ongoing Project: Emerging trends in rectal cancer: Understanding early-onset rectal cancer as a distinct disease entity.

    Languages Spoken

  • English
  • Nepali
  • Hindi
  • Bengali
  • Assamese
  • Overview

  • Dr. Rohit Tewari is a highly dedicated and academically driven Surgical Oncologist who specialises in managing complex oncologic, gastrointestinal (GI), hepato-pancreato-biliary (HPB), and minimally invasive surgeries. He holds a master's degree in General Surgery (MS) from R.G. Kar Medical College, Kolkata, and his super-speciality MCh in Surgical Oncology from the State Cancer Institute in Guwahati, a premier unit of Tata Trusts.

  • Throughout his career, he has built a massive cumulative experience, having performed and assisted in over 1,000 surgical oncology cases spanning various oncology disciplines. He regularly performs highly complex, major oncological resections independently, including VATS Esophagectomies, Whipple’s Pancreaticoduodenectomies, Radical Hysterectomies, Gastrostomies, and compartment resections for retroperitoneal tumours. He is heavily invested in minimally invasive treatment methods, possessing a Fellowship of Minimal Access Surgery (FMAS) and extensive hands-on training in advanced laparoscopy and robotic-assisted surgeries.

  • His surgical clinical expertise also covers specialised, regional treatments for advanced cancers, including Cytoreductive Surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). He has served across multiple renowned healthcare institutions, gaining valuable clinical perspective as a Consultant in Laparoscopic & General Surgery, a Senior Resident in Urology, and a Resident in Orthopaedics at Safdarjung Hospital, New Delhi. He is an active clinical researcher who has published in the prestigious Indian Journal of Surgical Oncology (2025) and is currently working on an active project studying emerging trends in early-onset rectal cancer. He is highly recognised within the national surgical community, having won the Best Video Presentation at IASO MIDCON 2025 alongside presenting his research at the Indian Cancer Congress and IASO NATCON. He holds active professional memberships in elite global and national oncology organisations, including the Society of Surgical Oncology (SSO), the Indian Association of Surgical Oncology (IASO), and the Association of Surgeons of India (ASI).

  • Field of Expertise

  • Gastrointestinal Oncology
  • Hepato-Pancreato-Biliary Surgery
  • Minimally Invasive & Robotic Surgery
  • Gynaecologic Oncology
  • Head and Neck Oncology
  • Peritoneal Surface Malignancy & HIPEC
  • Uro-Oncology
  • Awards & Achievements

  • Best Video Presentation- IASO MIDCON 2025 (Puri, Odisha)
  • Oral Paper Presentation- IASO NATCON 2024 (Bangalore, Karnataka)
  • Poster Presentation- Indian Cancer Congress 2023 (Mumbai, Maharashtra)
  • Poster & Video Presentation- ASI SASICON 2017 (Kolkata, West Bengal)
  • Talks & Publications

  • Dissertation: Evaluation of Metabolic Tumour Response to Neoadjuvant Therapy on 18F-FDG PET-CT Scan for Patients with Carcinoma of the Oesophagus as a Predictor of Pathological Response and Their Clinico-pathological Outcome.
  • Publication: Tewari R, et al. Suspicious Gallbladder Wall Thickening: A Tertiary Cancer Institute Observation on Malignant Potential. Indian Journal of Surgical Oncology, 2025.
  • Ongoing Project: Emerging trends in rectal cancer: Understanding early-onset rectal cancer as a distinct disease entity.

    Field of Expertise

  • Gastrointestinal Oncology
  • Hepato-Pancreato-Biliary Surgery
  • Minimally Invasive & Robotic Surgery
  • Gynaecologic Oncology
  • Head and Neck Oncology
  • Peritoneal Surface Malignancy & HIPEC
  • Uro-Oncology
  • Languages Spoken

  • English
  • Nepali
  • Hindi
  • Bengali
  • Assamese
  • Awards & Achievements

  • Best Video Presentation- IASO MIDCON 2025 (Puri, Odisha)
  • Oral Paper Presentation- IASO NATCON 2024 (Bangalore, Karnataka)
  • Poster Presentation- Indian Cancer Congress 2023 (Mumbai, Maharashtra)
  • Poster & Video Presentation- ASI SASICON 2017 (Kolkata, West Bengal)
  • Talks & Publications

  • Dissertation: Evaluation of Metabolic Tumour Response to Neoadjuvant Therapy on 18F-FDG PET-CT Scan for Patients with Carcinoma of the Oesophagus as a Predictor of Pathological Response and Their Clinico-pathological Outcome.
  • Publication: Tewari R, et al. Suspicious Gallbladder Wall Thickening: A Tertiary Cancer Institute Observation on Malignant Potential. Indian Journal of Surgical Oncology, 2025.
  • Ongoing Project: Emerging trends in rectal cancer: Understanding early-onset rectal cancer as a distinct disease entity.
  • Overview

  • Dr. Rohit Tewari is a highly dedicated and academically driven Surgical Oncologist who specialises in managing complex oncologic, gastrointestinal (GI), hepato-pancreato-biliary (HPB), and minimally invasive surgeries. He holds a master's degree in General Surgery (MS) from R.G. Kar Medical College, Kolkata, and his super-speciality MCh in Surgical Oncology from the State Cancer Institute in Guwahati, a premier unit of Tata Trusts.

  • Throughout his career, he has built a massive cumulative experience, having performed and assisted in over 1,000 surgical oncology cases spanning various oncology disciplines. He regularly performs highly complex, major oncological resections independently, including VATS Esophagectomies, Whipple’s Pancreaticoduodenectomies, Radical Hysterectomies, Gastrostomies, and compartment resections for retroperitoneal tumours. He is heavily invested in minimally invasive treatment methods, possessing a Fellowship of Minimal Access Surgery (FMAS) and extensive hands-on training in advanced laparoscopy and robotic-assisted surgeries.

  • His surgical clinical expertise also covers specialised, regional treatments for advanced cancers, including Cytoreductive Surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). He has served across multiple renowned healthcare institutions, gaining valuable clinical perspective as a Consultant in Laparoscopic & General Surgery, a Senior Resident in Urology, and a Resident in Orthopaedics at Safdarjung Hospital, New Delhi. He is an active clinical researcher who has published in the prestigious Indian Journal of Surgical Oncology (2025) and is currently working on an active project studying emerging trends in early-onset rectal cancer. He is highly recognised within the national surgical community, having won the Best Video Presentation at IASO MIDCON 2025 alongside presenting his research at the Indian Cancer Congress and IASO NATCON. He holds active professional memberships in elite global and national oncology organisations, including the Society of Surgical Oncology (SSO), the Indian Association of Surgical Oncology (IASO), and the Association of Surgeons of India (ASI).

    Awards & Achievements

  • Best Video Presentation- IASO MIDCON 2025 (Puri, Odisha)
  • Oral Paper Presentation- IASO NATCON 2024 (Bangalore, Karnataka)
  • Poster Presentation- Indian Cancer Congress 2023 (Mumbai, Maharashtra)
  • Poster & Video Presentation- ASI SASICON 2017 (Kolkata, West Bengal)
  • Field of Expertise

  • Gastrointestinal Oncology
  • Hepato-Pancreato-Biliary Surgery
  • Minimally Invasive & Robotic Surgery
  • Gynaecologic Oncology
  • Head and Neck Oncology
  • Peritoneal Surface Malignancy & HIPEC
  • Uro-Oncology
  • Languages Spoken

  • English
  • Nepali
  • Hindi
  • Bengali
  • Assamese
  • Talks & Publications

  • Dissertation: Evaluation of Metabolic Tumour Response to Neoadjuvant Therapy on 18F-FDG PET-CT Scan for Patients with Carcinoma of the Oesophagus as a Predictor of Pathological Response and Their Clinico-pathological Outcome.
  • Publication: Tewari R, et al. Suspicious Gallbladder Wall Thickening: A Tertiary Cancer Institute Observation on Malignant Potential. Indian Journal of Surgical Oncology, 2025.
  • Ongoing Project: Emerging trends in rectal cancer: Understanding early-onset rectal cancer as a distinct disease entity.
  • Overview

  • Dr. Rohit Tewari is a highly dedicated and academically driven Surgical Oncologist who specialises in managing complex oncologic, gastrointestinal (GI), hepato-pancreato-biliary (HPB), and minimally invasive surgeries. He holds a master's degree in General Surgery (MS) from R.G. Kar Medical College, Kolkata, and his super-speciality MCh in Surgical Oncology from the State Cancer Institute in Guwahati, a premier unit of Tata Trusts.

  • Throughout his career, he has built a massive cumulative experience, having performed and assisted in over 1,000 surgical oncology cases spanning various oncology disciplines. He regularly performs highly complex, major oncological resections independently, including VATS Esophagectomies, Whipple’s Pancreaticoduodenectomies, Radical Hysterectomies, Gastrostomies, and compartment resections for retroperitoneal tumours. He is heavily invested in minimally invasive treatment methods, possessing a Fellowship of Minimal Access Surgery (FMAS) and extensive hands-on training in advanced laparoscopy and robotic-assisted surgeries.

  • His surgical clinical expertise also covers specialised, regional treatments for advanced cancers, including Cytoreductive Surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). He has served across multiple renowned healthcare institutions, gaining valuable clinical perspective as a Consultant in Laparoscopic & General Surgery, a Senior Resident in Urology, and a Resident in Orthopaedics at Safdarjung Hospital, New Delhi. He is an active clinical researcher who has published in the prestigious Indian Journal of Surgical Oncology (2025) and is currently working on an active project studying emerging trends in early-onset rectal cancer. He is highly recognised within the national surgical community, having won the Best Video Presentation at IASO MIDCON 2025 alongside presenting his research at the Indian Cancer Congress and IASO NATCON. He holds active professional memberships in elite global and national oncology organisations, including the Society of Surgical Oncology (SSO), the Indian Association of Surgical Oncology (IASO), and the Association of Surgeons of India (ASI).

    Talks & Publications

  • Dissertation: Evaluation of Metabolic Tumour Response to Neoadjuvant Therapy on 18F-FDG PET-CT Scan for Patients with Carcinoma of the Oesophagus as a Predictor of Pathological Response and Their Clinico-pathological Outcome.
  • Publication: Tewari R, et al. Suspicious Gallbladder Wall Thickening: A Tertiary Cancer Institute Observation on Malignant Potential. Indian Journal of Surgical Oncology, 2025.
  • Ongoing Project: Emerging trends in rectal cancer: Understanding early-onset rectal cancer as a distinct disease entity.
  • Overview

  • Dr. Rohit Tewari is a highly dedicated and academically driven Surgical Oncologist who specialises in managing complex oncologic, gastrointestinal (GI), hepato-pancreato-biliary (HPB), and minimally invasive surgeries. He holds a master's degree in General Surgery (MS) from R.G. Kar Medical College, Kolkata, and his super-speciality MCh in Surgical Oncology from the State Cancer Institute in Guwahati, a premier unit of Tata Trusts.

  • Throughout his career, he has built a massive cumulative experience, having performed and assisted in over 1,000 surgical oncology cases spanning various oncology disciplines. He regularly performs highly complex, major oncological resections independently, including VATS Esophagectomies, Whipple’s Pancreaticoduodenectomies, Radical Hysterectomies, Gastrostomies, and compartment resections for retroperitoneal tumours. He is heavily invested in minimally invasive treatment methods, possessing a Fellowship of Minimal Access Surgery (FMAS) and extensive hands-on training in advanced laparoscopy and robotic-assisted surgeries.

  • His surgical clinical expertise also covers specialised, regional treatments for advanced cancers, including Cytoreductive Surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). He has served across multiple renowned healthcare institutions, gaining valuable clinical perspective as a Consultant in Laparoscopic & General Surgery, a Senior Resident in Urology, and a Resident in Orthopaedics at Safdarjung Hospital, New Delhi. He is an active clinical researcher who has published in the prestigious Indian Journal of Surgical Oncology (2025) and is currently working on an active project studying emerging trends in early-onset rectal cancer. He is highly recognised within the national surgical community, having won the Best Video Presentation at IASO MIDCON 2025 alongside presenting his research at the Indian Cancer Congress and IASO NATCON. He holds active professional memberships in elite global and national oncology organisations, including the Society of Surgical Oncology (SSO), the Indian Association of Surgical Oncology (IASO), and the Association of Surgeons of India (ASI).

  • Field of Expertise

  • Gastrointestinal Oncology
  • Hepato-Pancreato-Biliary Surgery
  • Minimally Invasive & Robotic Surgery
  • Gynaecologic Oncology
  • Head and Neck Oncology
  • Peritoneal Surface Malignancy & HIPEC
  • Uro-Oncology
  • Languages Spoken

  • English
  • Nepali
  • Hindi
  • Bengali
  • Assamese
  • Awards & Achievements

  • Best Video Presentation- IASO MIDCON 2025 (Puri, Odisha)
  • Oral Paper Presentation- IASO NATCON 2024 (Bangalore, Karnataka)
  • Poster Presentation- Indian Cancer Congress 2023 (Mumbai, Maharashtra)
  • Poster & Video Presentation- ASI SASICON 2017 (Kolkata, West Bengal)

FAQ's

Patients visit Dr. Rohit Tewari, a leading Consultant - Surgical Oncology at Manipal Hospitals Rangapani, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Rohit Tewari is a trusted choice for exceptional medical support.

You’re on Our Indian Website

Visit the Global site for International patient services

Need Assistance?
'Click' to chat with us
Chat with us